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The rise in the number of musculoskeletal disorders (MSDs) due to an increasingly aging population has
led to a growing demand for medication to prevent and treat these diseases. An increased interest in the
development of new drugs to allow treatment of these diseases in their very early stages is currently
observed. The current approach on local direct delivery of medication and key minerals to support bone
repair and regeneration at the defect site, from ﬂexible degradable devices, seems to be an effective
strategy. Polylactic acid (PLA) and microspheres of hydrothermally converted coralline hydroxyapatite
(cHAp) were used to develop PLA thin ﬁlm composites as drug delivery systems. The PLA provided
ﬂexibility and biodegradability of the systems, while coralline hydroxyapatite provided the required
calcium and phosphate ions for bone regeneration. These coralline hydroxyapatite microspheres have a
unique architecture of interconnected porosity, are bioactive in nature and suitable for drug loading and
controlled slow drug release. The cell attachment and morphology of the PLA thin ﬁlm composites were
evaluated in vitro using cell cultures of human adipose derived stem cells (hADSC). It was shown that
hADSC cells exhibited a strong attachment and proliferation on PLA thin ﬁlm cHAp composites, signi
fying high biocompatibility and a potential for osteointegration due to the presence of HAp.1. Introduction
Different types of cells have been used in tissue engineering and
in therapeutic strategies in cell therapy, including stem cell trans
plantation. Stem cells are primarily used to understand the mech
anisms by which natural or synthetic biomaterials are able to elicit
a cellular response when implanted in vivo. In the early days, adult
stem cells were used in this process but proved difﬁcult to grow in
culture because they were fully developed [1]. Attention was later
focused onto the use of fetal cells, which are not stem cells but
behaved similarly and better than adult cells when tested in
conjunction with biomaterials [1,2].l and Industrial Engineering,
laam, Tanzania.Stem cells are capable of continuous self renewal for an
extended period of time with minimal phenotypic changes. They
are also unspecialized and can be differentiated into mature func
tional cells in any of the dermal linages. The two most widely uti
lized adult stem cells are derived from bone marrow extracts and
adipose lipoaspirates and are termed as bone marrow stem cells
(BMSCs) and adipose derived stem cells (hADSCs), respectively.
BMSCs are involved in repair mechanisms during injury and have
been extensively investigated, speciﬁcally in orthopaedic
applications.
Biocompatibility of biomaterials involves three important
stages: adhesion of cells on the surface, proliferation and ﬁnally,
differentiation. When a biomaterial is implanted into a living body,
the biomaterial is rapidly coated with a protein layer before the
cells' attachment. Serum protein and various extracellular matrices
(ECM) are involved, such as ﬁbronectin, ﬁbrinogen, albumin and
vitronectin [3]. The protein adsorption and conformation is mainly
inﬂuenced by the morphology of the biomaterial surface, which
also inﬂuences the cell adhesion and proliferation process [4]. It has
been reported that micro/nano surface topography has a direct
impact on cell adhesion and proliferation, with a micro and nano
textured surface favouring adhesion.
Apart from the morphology, the surface charge and chemical
composition of the biomaterial surface has been suggested to play a
signiﬁcant role in the adhesion and proliferation of cells. Kese
lowsky et al. [5] showed that cell adhesion through the integrin
group of cell surface receptors, depends on the conformation of
adsorbed ﬁbronectin. In their demonstration, they used a self
assembly monolayer of different functional groups such as OH,
COOH, NH2 and CH3 termini, to create surfaces with different
chemistry that were hydrophilic and neutrally charged; hydrophilic
and acidic; hydrophilic and basic; and hydrophobic, respectively.
Their ﬁndings suggested that the adhesion strength of cell binding
(as determined by a centrifugation assay) followed the trend:
OH > COOH > NH2> CH3. They also found that the speciﬁc gene
expression of cells such as osteoblast, alkaline phosphatase enzyme
activity and matrix mineralization, showed dependence on surface
chemistry in which OH and NH2 terminated surfaces were more
advantageous, compared with COOH and CH3. Hydrophobic sur
faces seem to cause denaturation of proteins and prevent the sur
face exposure to cell binding groups responsible to cell adhesion.
On the other hand, hydrophilic and neutrally charged surfaces
induce the least extent of unfolding or denaturation, leading to a
good cell adhesion on the ﬁbronectin [6].
It has been reported that calcium phosphate bone substitutes
derived from mixed hydroxyapatite (HAp) and b tricalcium phos
phate (b TCP) are one of the most promising materials for bone
drug delivery systems. Major attention has been focused on theFig. 1. SEM picture of (a) coral solid piece showing the retained porous morphology after co
conversion to hydroxyapatite, d) converted coral piece showing platelets/needle-like morpdelivery of antibiotics, due to their wide areas of application as
prevention against infection during surgical interventions, or in
general in the treatment of bone related infections [7].
For slow drug delivery applications, ceramics and other mate
rials such as polymers and biocomposites have been proposed in
the past, but they are difﬁcult to form into an appropriate shape
with adequate interconnected micro porosity in order to be ﬁtted
into any type and size of bone defect. The treatment of bone
infection remains difﬁcult because of problems with the local
penetration of systemically administered antibiotics. Recently, Chu
et al. demonstrated that marine shells with speciﬁc micro spherical
design offer desired functions for the delivery of bisphosphonate
(paminodrate) and an antibiotic (gentamicin) [8]. This has been
possible by virtue of their unique structure and the architecture of
the foraminifera shells, which are extraordinarily difﬁcult to
manufacture currently [9,10].
In this paper, polylactic acid (PLA) and microspheres of hydro
thermally converted coralline hydroxyapatite (cHAp) were used to
develop PLA thin ﬁlm composites as drug delivery systems. PLA
provided ﬂexibility and biodegradability; whereas cHAp provided
bioactivity and osteoconductivity. The cell attachment and cell
morphology on PLA thin ﬁlm composites were evaluated in vitro
using cultures of human adipose derived stem cells (hADSC).
2. Materials and methods
Coral skeleton samples were obtained from the Great Barrier
Reef, QLD Australia; gentamicin sulfate, clodronate (dichlor
omethylenediphosphonic acid disodium salt), chloroform dia
mmonium hydrogen phosphate ((NH4)2HPO4, 98%), and sodium
hypochlorite (NaClO) were obtained from Sigma Aldrich, Castle Hill,
Australia. The PLA was purchased from NatureWorks Australia.nversion, b) coral solid piece before conversion for comparison, c) coralline piece after
hology of hydroxyapatite.
2.1. Porosity measurement
Porosity measurements were carried out with a mercury
intrusion porosimeter (Autopore III, Micromeritics Instruments
Inc., Norcross, GA, USA) with a 5 cm3 powder penetrometer.
2.2. PLA thin ﬁlm composites and drug loading
Hydrothermally converted coralline hydroxyapatite particles
were loaded with 10% w/w of gentamicin as described in previous
works [7,11]. The required amount of gentamicin was dissolved in
polished 18 MU water (MilliQ, Millipore, Victoria, Australia), mixed
with HAp, sonicated and then dried using a Rotavapor R 210
coupled with a V 850, BUCHI (In vitro Technologies, Australia,
vacuum controller) at 60 C. Gentamicin loaded cHAp micro
spheres were then dried in vacuumed desiccators and used to
produce PLA thin ﬁlm composites. Drug loading of the PLA ﬁlms
was performed as described by Macha et al. [12] by adding the
required amount of gentamicin or gentamicin loaded cHAp into
PLA chloroform solution to give 10% (w/w) drug in the composites
under magnetic stirring, followed by sonication to break down the
agglomerations of particles, cast in Petri dishes and then dried in a
desiccator under vacuum to produce transparent pore free thin
ﬁlms. The ﬁlms thickness were measured to be in the range
0.1e0.2 mm.
The samples for the stem cell experiments were cast into ster
ilized glass Petri dishes 60  15 mm. Before cell seeding, theFig. 2. Porosity within (a) coral powder; pore size and pore size distribution and b)
coral; evidence of pre-existing nanopores in a solid piece of coral.samples were sterilized in UV for 40 min.
Antibacterial efﬁcacy test was performed and presented in our
previously work [13]. Brieﬂy, an antimicrobial efﬁcacy test was
conducted in Tryptone Soya Broth (TSB). Inoculum density equiv
alent to 0.5 McFarland standards (1  108 CFU/ml) from overnight
culture, with a 50 ml TSB sub culture was used. PLA ﬁlm compos
ites loaded with gentamicin were either introduced in the begin
ning or after 90 min of bacterial growth in a dry incubator at
37 ± 0.1 C, with shaking at 220 rpm. The optical density of the
culture was monitored by spectrophotometer at 595 nm from the
experiment at time 0, which was immediately after introduction of
gentamicin loaded PLA ﬁlms, and every half an hour for the ﬁrst
6e6.5 h. When OD reaches about 1, samples were diluted to 1:10
before measurement. An additional time point was obtained after
24 h to check for recovery. Replicates of all experiments were done
in different days.2.3. Cell culture experiment
Human ADSCs were collected and used under University of
Technology Sydney (UTS) 2013000437 Santos and 2015000118
Santos ethics project approvals. The hADSCs were sourced and
cultured as per Santos et al., (Submitted,Stem Cell International).
The cell attachment and morphology were evaluated in vitro usingFig. 3. Hydrothermally coral-converted HAp (a) before gentamicin loading and (b)
after gentamicin loading.
cultures of human adipose derived stem cells (hADSC) at passage 5
in biological triplicates. Approximately 5  104 cells/ml were
seeded on glass Petri dishes with the cast samples in DMEM/F12
Glutmax (Gibco) 10% fetal bovine serum (Gibco) and incubated at
37 C, 5% CO2 for 7 days. Brieﬂy, the PLA and PLAGM samples were
coated with poly L lysine at room temperature for 30 min and
rinsed twice with phosphate buffered saline (pH 7.4) before cell
culture. Samples were washed with PBS (pH 7.4), ﬁxed in 4%
formaldehyde (Sigma) and then dehydrated in an ethanol gradient
from 10% to 100% at 10% increments at 10 min each, before the cells
were observed in SEM (ZEISS Supra55VP, Zeiss, Germany) operated
at 5 kV accelerated voltage, using a back scatter electron detector.Fig. 4. SEM image of hADSCs cultured PLA thin ﬁlm composites for 10 days, showing attachm
and ﬁlms of PLA, PLAGM, PLAHAp and PLAHApGM with no cells. These are clear and devoid
incubated with the cells. The image results show no cellular attachment of hADSCs to PLA
highly conﬂuent layer of attached homogenous hADSCs are present across the ﬁlms PLAHA3. Results and discussions
Fig. 1 shows the morphology of coralline materials hydrother
mally converted to hydroxyapatite in a phosphate solution. Fig. 1a
suggests that HAp retained the morphology of the original coral
after conversion.
Fig. 1d also shows coral after conversion, revealing the hy
droxyapatite platelet/needle like morphology. After ball milling
coralline particles still contain meso and nanopores for drug
loading and release. The porosity analysis of coral powder (Fig. 2),
shows the pore sizes in the range of 3 nme~350 mm. It was also
indicated that most of the crushed and ground particles have poreent and morphology of cells. The controls are presented on left hand column of media
of cells. The column on the right are the ﬁlms PLA, PLAGM, PLAHAp and PLAHApGM
or PLAGM with some precipitate forming on the latter. The ﬁnal two images exhibit a
p and PLAHApGM.
Fig. 5. SEM micrographs of cell cultured samples coated with poly-L-lysine a) PLA b) PLAGM.sizes around 4.5 mmwith a surface area determined to be 3.23m2/g.
The porosity of coral particles was determined to be 58% in the size
range considered (3 nm 350 nm). The results are consistent with
results reported previously, using Nuclear Magnetic Resonance
(NMR) [14].
Scanning electron microscopy (SEM) was used to conﬁrm the
physical presence of loaded drugs in HAp particles as shown in
Fig. 3. FTIR was used in previous work to evaluate any alteration of
drugs loaded in a PLA matrix [7]. Fig. 3 shows micrographs of HAp
before (Fig. 3a) and after loading with gentamicin (Fig. 3b). It is
evident that converted coral particles are coated with the drug on
the surface and into the micro, meso and nanopores, as the drug
solution could easily penetrate into these pores.
Synthetic polymeric biomaterials can only support cell adhesion
and proliferation to a limited extent due to the lack of functional
groups necessary for cell interaction [15]. Fig. 4 presents SEM im
ages showing the morphology and attachment of hADSC seeded on
PLA thin ﬁlm composites. The results show abundant cell attach
ment on PLAHAp and PLAHApGM samples, but no cell attachment
on PLA and PLAGM.
PLA has an alkyl pendant group (CH3 ) in its backbone, which
makes the polymer more hydrophobic and tends to denaturalize
proteins responsible for cell binding and adhesion. Gentamicin has
NH2 groups, which with the CH3 groups on the polymer back
bone, reduce any chance for protein binding on the surface. This
was evident because PLA and PLGM samples do not show any cells
on their surfaces. The addition of hydroxyapatite (HAp) in the
matrix results in an improvement of bioactivity of composite ﬁlms
by changing the surface chemistry from hydrophobic to hydro
philic. The presence of eOH groups due to HAp on the other hand,
favours the binding of adhesive proteins such as vitronectin and
ﬁbronectin and subsequently cellular interaction [16]. There are
several methods currently used to treat biomaterial surfaces in
order to improve their biocompatibility, including physical, chem
ical and mechanical treatments. Surface treatments such as expo
sure to plasma, formation of coatings, corona discharge,
implantation of ions and ultraviolet (UV) ozone treatments can
enhance cell attachment. Speciﬁc functional groups can be also
covalently attached to biomaterial surfaces using chemical modi
ﬁcation methods, to attach for example biomolecules [3].
In order to conﬁrm the lack of protein adsorption on the surface
of the PLA and PLAGM samples, theywere coatedwith poly L lysine
as an attachment factor to enhance the electrostatic interactions
between negatively charged ions of the cell membrane and posi
tively charged ions of the culture surface, by increasing the number
of positively charged sites available for cell binding. The results
suggest that cells were able to attach on the PLA and PLAGM sur
faces after coating with poly L lysine in less than 24 h as shown in
Fig. 5.4. Conclusions
The study of PLAecalcium phosphate thin ﬁlm composites re
veals possible potential applications of these devices as drug de
livery systems in the biomedical ﬁeld. The ﬂexibility they provide
allows them to conform to any desired clinical shape and size.
Incorporation of hydroxyapatite in the matrix has the added
advantage of improving bioactivity and the continuous supply of
calcium Ca2þ and phosphate PO43 ions which can assist in bone
regeneration and repair. On one hand, PLAHAp and PLAHApGM
display a strong afﬁnity to hADSC, due to the presence of HAp in the
polymeric matrix. On the other hand, a lack of cell attachment on
the PLA and PLAGM could be observed. Coating PLA and PLAGM
surfaces with poly L lysine reveals the possibility of surface treat
ments that can enhance cell attachment, which could be of medical
importance. Although, not carried out here, possibly other surface
methods like plasma treatments could also be employed to render
the surfaces suitable for protein binding. The use of PLA HAp
composites as drug release systems with excellent biocompati
bility could pave the way for a new generation of drug delivery
systems for bone regeneration.
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